155 related articles for article (PubMed ID: 27386502)
1. Impaired muscle uptake of creatine in spinal and bulbar muscular atrophy.
Hijikata Y; Katsuno M; Suzuki K; Hashizume A; Araki A; Yamada S; Inagaki T; Iida M; Noda S; Nakanishi H; Banno H; Mano T; Hirakawa A; Adachi H; Watanabe H; Yamamoto M; Sobue G
Ann Clin Transl Neurol; 2016 Jul; 3(7):537-46. PubMed ID: 27386502
[TBL] [Abstract][Full Text] [Related]
2. Treatment with Creatine Monohydrate in Spinal and Bulbar Muscular Atrophy: Protocol for a Randomized, Double-Blind, Placebo-Controlled Trial.
Hijikata Y; Katsuno M; Suzuki K; Hashizume A; Araki A; Yamada S; Inagaki T; Ito D; Hirakawa A; Kinoshita F; Gosho M; Sobue G
JMIR Res Protoc; 2018 Mar; 7(3):e69. PubMed ID: 29506970
[TBL] [Abstract][Full Text] [Related]
3. Decreased Peak Expiratory Flow Associated with Muscle Fiber-Type Switching in Spinal and Bulbar Muscular Atrophy.
Yamada S; Hashizume A; Hijikata Y; Inagaki T; Suzuki K; Kondo N; Kawai K; Noda S; Nakanishi H; Banno H; Hirakawa A; Koike H; Halievski K; Jordan CL; Katsuno M; Sobue G
PLoS One; 2016; 11(12):e0168846. PubMed ID: 28005993
[TBL] [Abstract][Full Text] [Related]
4. Increased mitophagy in the skeletal muscle of spinal and bulbar muscular atrophy patients.
Borgia D; Malena A; Spinazzi M; Desbats MA; Salviati L; Russell AP; Miotto G; Tosatto L; Pegoraro E; Sorarù G; Pennuto M; Vergani L
Hum Mol Genet; 2017 Mar; 26(6):1087-1103. PubMed ID: 28087734
[TBL] [Abstract][Full Text] [Related]
5. Muscle and not neuronal biomarkers correlate with severity in spinal and bulbar muscular atrophy.
Lombardi V; Querin G; Ziff OJ; Zampedri L; Martinelli I; Heller C; Foiani M; Bertolin C; Lu CH; Malik B; Allen K; Rinaldi C; Zetterberg H; Heslegrave A; Greensmith L; Hanna M; Soraru G; Malaspina A; Fratta P
Neurology; 2019 Mar; 92(11):e1205-e1211. PubMed ID: 30787165
[TBL] [Abstract][Full Text] [Related]
6. [Molecular pathogenesis of motor neuron diseases].
Sobue G
Nihon Shinkei Seishin Yakurigaku Zasshi; 2001 Feb; 21(1):21-25. PubMed ID: 11400322
[TBL] [Abstract][Full Text] [Related]
7. Androgen-dependent loss of muscle BDNF mRNA in two mouse models of SBMA.
Halievski K; Henley CL; Domino L; Poort JE; Fu M; Katsuno M; Adachi H; Sobue G; Breedlove SM; Jordan CL
Exp Neurol; 2015 Jul; 269():224-32. PubMed ID: 25929689
[TBL] [Abstract][Full Text] [Related]
8. Mutant androgen receptor accumulation in spinal and bulbar muscular atrophy scrotal skin: a pathogenic marker.
Banno H; Adachi H; Katsuno M; Suzuki K; Atsuta N; Watanabe H; Tanaka F; Doyu M; Sobue G
Ann Neurol; 2006 Mar; 59(3):520-6. PubMed ID: 16358333
[TBL] [Abstract][Full Text] [Related]
9. The reduction of androgen receptor mRNA in motoneurons of X-linked spinal and bulbar muscular atrophy.
Nakamura M; Mita S; Matuura T; Nagashima K; Tanaka H; Ando M; Uchino M
J Neurol Sci; 1997 Sep; 150(2):161-5. PubMed ID: 9268245
[TBL] [Abstract][Full Text] [Related]
10. Expression of Human Endogenous Retrovirus-K in Spinal and Bulbar Muscular Atrophy.
Rex C; Nadeau MJ; Douville R; Schellenberg K
Front Neurol; 2019; 10():968. PubMed ID: 31551920
[No Abstract] [Full Text] [Related]
11. Myoglobin: a new biomarker for spinal and bulbar muscular atrophy?
Guo H; Lu M; Ma Y; Liu X
Int J Neurosci; 2021 Dec; 131(12):1209-1214. PubMed ID: 32729750
[TBL] [Abstract][Full Text] [Related]
12. [Study of androgen receptor expression and neuronal vulnerability in X-linked spinal and bulbar muscular atrophy].
Matsuura T
Hokkaido Igaku Zasshi; 1996 Nov; 71(6):785-99. PubMed ID: 8996845
[TBL] [Abstract][Full Text] [Related]
13. Skeletal muscle MRI differentiates SBMA and ALS and correlates with disease severity.
Klickovic U; Zampedri L; Sinclair CDJ; Wastling SJ; Trimmel K; Howard RS; Malaspina A; Sharma N; Sidle K; Emira A; Shah S; Yousry TA; Hanna MG; Greensmith L; Morrow JM; Thornton JS; Fratta P
Neurology; 2019 Aug; 93(9):e895-e907. PubMed ID: 31391248
[TBL] [Abstract][Full Text] [Related]
14. ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor.
Yang Z; Chang YJ; Yu IC; Yeh S; Wu CC; Miyamoto H; Merry DE; Sobue G; Chen LM; Chang SS; Chang C
Nat Med; 2007 Mar; 13(3):348-53. PubMed ID: 17334372
[TBL] [Abstract][Full Text] [Related]
15. Correlation of insulin resistance and motor function in spinal and bulbar muscular atrophy.
Nakatsuji H; Araki A; Hashizume A; Hijikata Y; Yamada S; Inagaki T; Suzuki K; Banno H; Suga N; Okada Y; Ohyama M; Nakagawa T; Kishida K; Funahashi T; Shimomura I; Okano H; Katsuno M; Sobue G
J Neurol; 2017 May; 264(5):839-847. PubMed ID: 28229243
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy.
Adachi H; Waza M; Katsuno M; Tanaka F; Doyu M; Sobue G
Neuropathol Appl Neurobiol; 2007 Apr; 33(2):135-51. PubMed ID: 17359355
[TBL] [Abstract][Full Text] [Related]
17. Convenient diagnosis of spinal and bulbar muscular atrophy using a microchip electrophoresis system.
Maruyama H; Morino H; Izumi Y; Noda K; Kawakami H
Am J Neurodegener Dis; 2013; 2(1):35-9. PubMed ID: 23515294
[TBL] [Abstract][Full Text] [Related]
18. Serum creatine kinase levels in spinobulbar muscular atrophy and amyotrophic lateral sclerosis.
Chahin N; Sorenson EJ
Muscle Nerve; 2009 Jul; 40(1):126-9. PubMed ID: 19533663
[TBL] [Abstract][Full Text] [Related]
19. Transgenic mouse models of spinal and bulbar muscular atrophy (SBMA).
Katsuno M; Adachi H; Inukai A; Sobue G
Cytogenet Genome Res; 2003; 100(1-4):243-51. PubMed ID: 14526186
[TBL] [Abstract][Full Text] [Related]
20. Biomarker-based analysis of preclinical progression in spinal and bulbar muscular atrophy.
Hijikata Y; Hashizume A; Yamada S; Inagaki T; Ito D; Hirakawa A; Suzuki K; Atsuta N; Tsuboi T; Hattori M; Hori A; Banno H; Sobue G; Katsuno M
Neurology; 2018 Apr; 90(17):e1501-e1509. PubMed ID: 29572281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
